BackgroundFew studies have identified the willingness rate of developing countries population to be enrolled in clinical trials.MethodsAll participants including patients, healthy volunteers and doctors completed a questionnaire to examine factors affecting the consent to participate in medical research.ResultsOverall, 80 % of the included population agree to participate in health research. This rate was lower for trials dealing with life-threatening diseases. Altruism and perceived risk of harm were the main reason to respectively accept or refuse to participate in clinical trials. Factors (...) significantly associated with willingness were: age <40 years 1.6 [95 % Confidence Interval 1.2-2.1]) and prior history of blood donation.ConclusionMost participants expressed their willingness to be included in medical research especially if they are young or if they have history of blood donation. However, consent to participate is low when medical research required acute care. (shrink)

The etiology of schizophrenia remains heavily contested despite extensive research, huge quantities of data, and heavy investment in time and material resources around the world. Not only is there little agreement about the causes of this most devastating of psychiatric conditions, but there is disagreement as to whether the condition exists at all as a coherent entity (Bentall 2006). Evolutionary theorists have had the added problem of explaining how a severe mental illness that causes a significant reproductive disadvantage can continue (...) to exist in human populations, where it is claimed to have a uniform prevalence across the world. Many Darwinian formulations have suggested various forms of tradeoffs where the .. (shrink)

B2B online reverse auctions technology (ORAs) emerged as a popular tool for large buying firms in the late 1990s. However, its growing use has been accompanied by a corresponding increase in unethical behaviors to a point that it has been described as the technology that has triggered more ethical concerns in the e-commerce arena than in any other segment of activity. Our findings first indicate that the establishment of formal ethical criteria based on the restrictive interpretation of ethics as honesty (...) is not enough to resolve the ethical issues that surround the introduction of a technology because it ignores the ethical values shared by most acton in the sector in terms of fairness. We show the extent to which lobbying, rumor, technical problems, and public discourse can impact on the interpretations of the technology regarding ethics. Highlighting the importance of incorporating ORAs into the broader context of relationship management that integrates ethics as fairness and not only ethics as honesty serves to illustrate why the future of ORAs might not be as bright as predicted by a theoretical interpretation of the technology that is sometimes disconnected from the realities of the field. (shrink)